{"ModuleTitle": "Company Description", "CompanyName": "ARCA biopharma, Inc.", "Symbol": "ABIO", "Address": "11080 CIRCLEPOINT ROAD SUITE 140, WESTMINSTER, Colorado, 80020, United States of America", "Phone": "720-940-2200", "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "Some of the statements under \"Business,\" \"Risk Factors,\" \"Management's\r\nDiscussion and Analysis of Financial Condition and Results of Operations\" and\r\nelsewhere in this Annual Report constitute forward-looking statements. In some\r\ncases, you can identify forward-looking statements by the following words:\r\n\"may,\" \"will,\" \"could,\" \"would,\" \"should,\" \"expect,\" \"intend,\" \"plan,\"\r\n\"anticipate,\" \"believe,\" \"estimate,\" \"predict,\" \"project,\" \"potential,\"\r\n\"continue,\" \"ongoing\" or the negative of these terms or other comparable\r\nterminology, although not all forward-looking statements contain these words.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f18%2f0001564590-20-005032.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Michael R. Bristow", "title": "President, Chief Executive Officer & Director"}, {"name": "Thomas A. Keuer", "title": "Chief Operating Officer"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}